Group 1 - The company Micro Yuan Synthetic Biotechnology (Beijing) Co., Ltd. is innovating in biosynthesis technology to produce allulose, a low-calorie sweetener that helps with blood sugar control and weight management [1] - Allulose production has been optimized from a two-step reaction to a one-step process, increasing conversion efficiency from 10% to over 80%, and reducing production costs by approximately 50% [1] - The first phase of the allulose production facility has been officially launched, with an annual production capacity reaching tens of thousands of tons [1] Group 2 - Changping District is focusing on developing synthetic biology manufacturing, with over 120 companies in the sector and projected industry revenue exceeding 6 billion yuan in 2024 [2] - The district aims to become a leading hub for synthetic biology innovation and has attracted significant investment in various subfields, including biobased materials and gas fermentation [2] - Notable companies in the area include Jitai Laibo Biotechnology and Qihe Biotechnology, which are making significant advancements in carbon fixation and plant cell gene editing, respectively [2]
北京昌平发展合成生物制造产业 未来科学城有座“健康糖工厂”
Ren Min Ri Bao·2025-08-06 22:14